Red Queen Therapeutics Funding: $55M Raised, Series A (2024)
Red Queen Therapeutics is based in Cambridge, Massachusetts. It has raised $55M in total funding. Latest round: Series A.
Red Queen Therapeutics funding overview
Red Queen Therapeutics is based in Cambridge, Massachusetts. Red Queen Therapeutics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2024. The round record for Red Queen Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Apple Tree Partners, Biomedical Advanced Research and Development Authority (BAR…. 2 distinct backers are named across the disclosed rounds.
Red Queen Therapeutics at a glance
Total raised
$55M
Latest round
Series A
Latest round date
August 2024
Headquarters
Cambridge, Massachusetts
Notable investors
Apple Tree Partners, Biomedical Advanced Research and Development Authority (BAR…
Frequently asked about Red Queen Therapeutics funding
How much has Red Queen Therapeutics raised?
Red Queen Therapeutics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Red Queen Therapeutics?
Apple Tree Partners, Biomedical Advanced Research and Development Authority (BAR… are named among the investors backing Red Queen Therapeutics.
What was the latest Red Queen Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2024.
Where is Red Queen Therapeutics based?
Red Queen Therapeutics is based in Cambridge, Massachusetts.
When did Red Queen Therapeutics last raise?
The last disclosed Red Queen Therapeutics round closed in August 2024 at Series A.
Every Red Queen Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
